Total raised
$2.3M
Stage
Pre-Funding
Founded
2020
Headcount
5
HQ
Rehovot
Sector
Health Tech & Life Sciences
About
Pentaomix is developing a novel modality for digital pathology that aims to revolutionize the ability of doctors to match each cancer patient with the right drug. The companys system is based on hyperspectral imaging and AI algorithms to enable a deeper understanding of the tumors microenvironment and a holistic viewpoint of the tumor progression. The Pentaomix system will enable a shorter development time for cancer drug biomarkers and improved screening for clinical studies, and will eventually serve as a companion diagnostic in hospitals.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceComputer VisionImage RecognitionDeep LearningSensingChromatics & Light
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersLaboratoriesMedical Devices IndustryMedical Equipment
Business model
B2B
Highlights
1 PatentsVerified
Tags
decision-supportoncologyhospitalscancerdiagnosticsdigital-healthcarehealthcare-providersimagingdoctorsalgorithmsbiopsypharma-companiesdrug-developmentprecision-medicineartificial-intelligence